928,000 IU/mLThe median HCV viral load was 928000 IU/mL.
Camerounhépatite Cpublished 2009HIV MedicineOpenAlexdocument of 5 observations
Gold tier: mechanically validated evidence, with its primary source.
1,754 evidence items · page 21 / 71
928,000 IU/mLThe median HCV viral load was 928000 IU/mL.
Camerounhépatite Cpublished 2009HIV MedicineOpenAlexdocument of 5 observations
59.2 %Malaria prevalence among the asymptomatic individuals reached 59.2% (876/1480) in Mfou.
CamerounpaludismeHAL · Unilimdocument of 106 observations
80.4 %At day 3, 74 out of 92 participants (80.4%) on doxycycline were asymptomatic.
CamerounCOVID-19published 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument of 8 observationsDOI 10.1101/2021.07.25.21260838
10 animalsDual HTLV-1 and HTLV-2 infection was confirmed in 10 animals.
CamerounHTLV-1 and HTLV-2observed 1999 to 2002published 2004Journal of VirologyOpenAlexdocument of 6 observations
128.1 mm_HgIn 2008, age-standardised mean systolic blood pressure worldwide was 128.1 mm Hg in men.
Camerounhypertension artérielleobserved 2008published 2011Lancet (London, England)europe_pmcdocument of 10 observations
0.02 %HIV-1 group N and P and HIV-2 prevalence in Cameroon was very low (<0.02%).
CamerounHIV-1 group N and P and HIV-2observed 2006 to 2013published 2015Infection, genetics and evolution : journal of molecular epidemiology and evolutionary geneurope_pmcdocument of 4 observations
9 casesAmong the 80 COVID-19 positive patients, hypertension was present in 9 (11.3%), diabetes mellitus in 7 (8.8%), cardiovascular disease in 8 (10%), and obesity in 4 (5%).
CamerounCOVID-19 · hypertension artériellepublished 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
66.9 %IADPSG criteria independently identified at least 66.9% of gestational diabetes cases in the studied Cameroonian population.
Cameroundiabète gestationnelpublished 2023Frontiers in clinical diabetes and healthcareeurope_pmcdocument of 9 observationsDOI 10.3389/fcdhc.2023.1272333
32.1 %Hypertension prevalence in Cameroon was 32.1% [95% CI 27.2–37.1] during 2011–2018.
Camerounhypertension artérielleobserved 2011-2018published 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165
2,000 mg/kgIn acute toxicity, single oral administration of 2000 mg/kg of methanol extract of Eriosema laurentii caused neither toxicological symptoms nor mortality.
Camerountoxicitypublished 2014Food and chemical toxicology : an international journal published for the British Industrieurope_pmcdocument of 9 observations
47 %Additional benefit on strokes occurring on treatment from tighter blood pressure control on therapy could be up to 47% in both urban Cameroon men and European women.
Camerounhypertension artériellepublished 2001Journal of hypertensioneurope_pmcdocument of 7 observationsDOI 10.1097/00004872-200101000-00006
5.8 %Stroke was the underlying cause of 5.8% of diabetic comas admitted to the endocrinology service of Yaounde Central Hospital between November 1999 and October 2002.
CamerounAVC · comaobserved November 1999 to October 2002published 2008Annals of tropical medicine and parasitologyeurope_pmcdocument of 12 observationsDOI 10.1179/136485908x252188
2,800,000 deaths_per_yearExcess weight alone currently accounts for at least 2.8 million deaths globally each year through increased risk for type 2 diabetes and cardiovascular complications.
Camerouncardiovascular complications · diabète de type 2published 2014Current diabetes reportseurope_pmcdocument of 2 observations
65.2 %On day 10, 60 out of 92 participants (65.2%) assigned to doxycycline had a negative SARS-CoV-2 PCR test.
CamerounCOVID-19published 2023Cureuseurope_pmcdocument of 7 observations
80.3 %The treatment rate for hypertension among those aware of their hypertension status was 80.3%.
Camerounhypertension artériellepublished 2007Diabetes research and clinical practiceeurope_pmcdocument of 5 observations
29 %SIVcpz prevalence rates in some wild-living Pan troglodytes troglodytes communities in southern Cameroon reached 29 to 35%.
CamerounSIVcpzpublished 2006ScienceOpenAlex
10.6 %Macula edema was found in 21 angiographies (10.6%).
Camerounmacula edemaobserved November 2007 to December 2008published 2010Sante (Montrouge, France)europe_pmcdocument of 8 observations
99 %In 2023, almost 99% of malaria cases were due to Plasmodium falciparum.
Camerounpaludismeobserved 2023HAL · Unilimdocument of 106 observations
0.6 %HbA1c dropped by 0.6 % after 12 months.
Cameroundiabète de type 1observed 12 monthspublished 2016BMC endocrine disorderseurope_pmcdocument of 6 observations
Homeostatic model assessment of β-cell function (HOMA-β) was significantly higher among HHV8 antibody-positive than HHV8 antibody-negative participants.
Cameroundiabète (non précisé) · HHV8published 2018Journal of diabeteseurope_pmcdocument of 10 observations
-6.74 beta_coefficientIn age, sex and body mass index adjusted models, increasing Log10LTL was associated with decreasing diastolic blood pressure (β = -6.74).
Camerouncardio-metabolic diseasespublished 2022Medicineeurope_pmcdocument of 12 observations
33.3 %As of 29 September 2024, Cameroon has reported a total of 89 suspected mpox cases, with 6 confirmed cases and 2 deaths, resulting in a case fatality rate of 33.3%.
Camerounmpoxobserved 29 September 2024Africa CDCdocument of 147 observations
0.29 nmol/molStimulated Urinary C-Peptide to Creatinine Ratio was lower in type 1 diabetes compared to control participants, with median values of 0.29 nmol/mol vs. 1.21 nmol/mol.
Cameroundiabète de type 1published 2022Frontiers in public healtheurope_pmcdocument of 6 observationsDOI 10.3389/fpubh.2022.866107
78.6 %Against the susceptible Kisumu strain, LLINs washed with local soap showed 78.6% efficacy in Eyang.
CamerounpaludismeHAL · Unilimdocument of 89 observations
30.9 %Overall hypertension prevalence in Cameroon was 30.9% [95% confidence interval (CI) 27.0–34.8].
Camerounhypertension artériellepublished 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.